|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019704,
umls-concept:C0021311,
umls-concept:C0087111,
umls-concept:C0205265,
umls-concept:C0205466,
umls-concept:C0209738,
umls-concept:C0231174,
umls-concept:C0384228,
umls-concept:C0663655,
umls-concept:C1555582,
umls-concept:C2603343
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-2-2
|
|
pubmed:abstractText |
To assess the efficacy and safety of the triple NRTI combination of abacavir (ABC), lamivudine (3TC), and tenofovir (TDF) in a once-daily regimen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1528-4336
|
|
pubmed:author |
pubmed-author:BenalycherifAA,
pubmed-author:BentataMM,
pubmed-author:BonnerDD,
pubmed-author:Brun VezinetFF,
pubmed-author:DescampsDD,
pubmed-author:FlandrePP,
pubmed-author:GirardP MPM,
pubmed-author:KatlamaCC,
pubmed-author:LandmanRR,
pubmed-author:MichelerAA,
pubmed-author:MillerM DMD,
pubmed-author:PeytavinGG,
pubmed-author:TONUS (IMEA 021) Study Group,
pubmed-author:TrylesinskiAA,
pubmed-author:YeniPP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
291-301
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16452063-Adult,
pubmed-meshheading:16452063-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16452063-CD4 Lymphocyte Count,
pubmed-meshheading:16452063-Dideoxynucleosides,
pubmed-meshheading:16452063-Female,
pubmed-meshheading:16452063-Genotype,
pubmed-meshheading:16452063-HIV Infections,
pubmed-meshheading:16452063-HIV-1,
pubmed-meshheading:16452063-Humans,
pubmed-meshheading:16452063-Lamivudine,
pubmed-meshheading:16452063-Male,
pubmed-meshheading:16452063-Middle Aged,
pubmed-meshheading:16452063-Patient Compliance,
pubmed-meshheading:16452063-Pilot Projects,
pubmed-meshheading:16452063-Prospective Studies,
pubmed-meshheading:16452063-RNA, Viral,
pubmed-meshheading:16452063-Reverse Transcriptase Inhibitors
|
|
pubmed:articleTitle |
Early virologic failure and rescue therapy of tenofovir, abacavir, and lamivudine for initial treatment of HIV-1 infection: TONUS study.
|
|
pubmed:affiliation |
Bichat Claude Bernard Hospital, Paris, France. landman@bichat.inserm.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
